Literature DB >> 5667267

Formation of an unusual hybrid in the development of human adenosine 5'-triphosphate-creatine phosphotransferase.

I Kumudavalli, D C Watts.   

Abstract

1. Starch-gel analysis of extracts from adult human muscle, heart and brain reveals a hybrid creatine kinase with an abnormally high electrophoretic mobility. 2. Hybridization in vitro confirms that the postulated hybrid is formed from a combination of brain- and muscle-type enzyme sub-units. 3. The relative electrophoretic mobility of the hybrid is not affected by changing the starch concentration in the gel or by the buffer system used, or by electrophoresis in thin layers of Sephadex. 4. It is concluded that hybrid formation results in a net increase on the dimeric enzyme of from 4 to 6 negative charges. 5. During development a sharp increase in the rate of production of muscle-type enzyme sub-units occurs in heart at 10-13 weeks' gestation and in muscle at 18-20 weeks' gestation. The latter change is accompanied by a relative decrease in the concentration of brain-type sub-units.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5667267      PMCID: PMC1198849          DOI: 10.1042/bj1080547

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  Identification of the abnormal polypeptide chain of hemoglobin G-Ib.

Authors:  D B GAMMACK; E R HUEHNS; E M SHOOTER; P S GERALD
Journal:  J Mol Biol       Date:  1960-12       Impact factor: 5.469

2.  An improved procedure for starch-gel electrophoresis: further variations in the serum proteins of normal individuals.

Authors:  O SMITHIES
Journal:  Biochem J       Date:  1959-03       Impact factor: 3.857

3.  Starch gel electrophoresis in a discontinous system of buffers.

Authors:  M D POULIK
Journal:  Nature       Date:  1957-12-28       Impact factor: 49.962

4.  Adenosinetriphosphate-creatine transphosphorylase. II. Homogeneity and physicochemical properties.

Authors:  L NODA; S A KUBY; H A LARDY
Journal:  J Biol Chem       Date:  1954-07       Impact factor: 5.157

5.  Creatine phosphokinase isoenzymes.

Authors:  S B Rosalki
Journal:  Nature       Date:  1965-07-24       Impact factor: 49.962

6.  Genetics of the alkaline phosphatase polymorphism of the human placenta.

Authors:  E B Robson; H Harris
Journal:  Nature       Date:  1965-09-18       Impact factor: 49.962

7.  Creatine kinase: evidence for a dimeric structure.

Authors:  D M Dawson; H M Eppenberger; N O Kaplan
Journal:  Biochem Biophys Res Commun       Date:  1965-11-22       Impact factor: 3.575

8.  Evolution of creatine kinase.

Authors:  M E Eppenberger; H M Eppenberger; N O Kaplan
Journal:  Nature       Date:  1967-04-15       Impact factor: 49.962

9.  Studies on adenosine triphosphate transphophorylases. V. Studies on the polypeptide chains of the crystalline adenosine triphosphate-creatine transphosphorylase from rabbit skeletal muscle.

Authors:  R H Yue; R H Palmieri; O E Olson; S A Kuby
Journal:  Biochemistry       Date:  1967-10       Impact factor: 3.162

10.  Phosphagen kinases and evolution in the echinodermata.

Authors:  B Moreland; D C Watts; R Virden
Journal:  Nature       Date:  1967-04-29       Impact factor: 49.962

View more
  3 in total

1.  Properties and reaction with iodoacetamide of adenosine 5'-triphosphate-creatine phosphotransferase from human skeletal muscle. Further evidence about the role of the essential thiol group in relation to the mechanism of action.

Authors:  I Kumudavalli; B H Moreland; D C Watts
Journal:  Biochem J       Date:  1970-04       Impact factor: 3.857

2.  Purification and properties of adenosine triphosphate-creatine phosphotransferase from muscle of the dogfish Scylliorhinus canicula.

Authors:  B Simonarson; D C Watts
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857

3.  Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and creatine kinase activity and isoenzymes in human brain tumours.

Authors:  N Durany; J Joseph; F F Cruz-Sánchez; J Carreras
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.